Featured Article

Xylem Pricing Spineometer: 3 of 5 Vertebrae

By Tim J. Smith, PhD December 17, 2024

Xylem, a global water treatment company, had a positive Q3 2024. Revenue rose 1.3 % to $2.1 billion and earnings before interest and taxes rose 47% to $280 million over the same period last year. A review of Xylem’s 31 October 2024 earnings call and associated financial reports provided insight regarding the importance of pricing on performance. Mathew Pine, the CEO of Xylem since January this year, was proud of his team’s…

Read More

In This Issue

Masco Pricing Spineometer: 3 of 5 Vertebrae

By Tim J. Smith, PhD October 25, 2024

Masco, an architectural coating (paint) and plumbing company had an unremarkable Q2 2024. Revenue fell slightly by 1.7% to $2.1 billion and…

Read More

Johnson Controls Pricing Spineometer: 5 of 5 Vertebrae

By Tim J. Smith, PhD September 26, 2024

Johnson Controls, an engineered environmental solutions company, had a positive Q3 2024. Revenue rose 1.4% to 7.2 billion and earnings before interest…

Read More

Lilly Pricing Spineometer: 5 of 5 Vertebrae

By Tim J. Smith, PhD September 26, 2024

Lilly, a global pharmaceutical company, had a strongly positive Q2 2024. Revenue rose 36% to $11.3 billion and earnings before interest and…

Read More

Marriott Pricing Spineometer: 5 of 5 Vertebrae

By Tim J. Smith, PhD September 26, 2024

Marriott, a global hospitality concern operating hotels, residential communities, and timeshare, had a positive Q2 2024. Revenue rose 6.0% to $6.4 billion…

Read More

WIGLAF, STRAIGHT
TO YOUR INBOX